Fulvia Daffara

3.6k total citations
37 papers, 1.9k citations indexed

About

Fulvia Daffara is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Fulvia Daffara has authored 37 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Surgery, 24 papers in Endocrinology, Diabetes and Metabolism and 18 papers in Cancer Research. Recurrent topics in Fulvia Daffara's work include Adrenal and Paraganglionic Tumors (29 papers), Cancer, Hypoxia, and Metabolism (18 papers) and Pituitary Gland Disorders and Treatments (17 papers). Fulvia Daffara is often cited by papers focused on Adrenal and Paraganglionic Tumors (29 papers), Cancer, Hypoxia, and Metabolism (18 papers) and Pituitary Gland Disorders and Treatments (17 papers). Fulvia Daffara collaborates with scholars based in Italy, United States and Germany. Fulvia Daffara's co-authors include Massimo Terzolo, Marco Volante, Giuseppe Reimondo, Alberto Angeli, Barbara Zaggia, Alfredo Berruti, F. Porpiglia, Mauro Papotti, Silvia Bovio and P. Paccotti and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Clinical Cancer Research.

In The Last Decade

Fulvia Daffara

36 papers receiving 1.8k citations

Peers

Fulvia Daffara
Anna Pia Italy
Fulvia Daffara
Citations per year, relative to Fulvia Daffara Fulvia Daffara (= 1×) peers Anna Pia

Countries citing papers authored by Fulvia Daffara

Since Specialization
Citations

This map shows the geographic impact of Fulvia Daffara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fulvia Daffara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fulvia Daffara more than expected).

Fields of papers citing papers by Fulvia Daffara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fulvia Daffara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fulvia Daffara. The network helps show where Fulvia Daffara may publish in the future.

Co-authorship network of co-authors of Fulvia Daffara

This figure shows the co-authorship network connecting the top 25 collaborators of Fulvia Daffara. A scholar is included among the top collaborators of Fulvia Daffara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fulvia Daffara. Fulvia Daffara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Porpiglia, F., Cristian Fiori, Fulvia Daffara, et al.. (2015). Does nephrectomy during radical adrenalectomy for stage II adrenocortical cancer affect patient outcome?. Journal of Endocrinological Investigation. 39(4). 465–471. 11 indexed citations
2.
Duregon, Eleonora, Ida Rapa, Jessica Giorcelli, et al.. (2014). MicroRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations. Human Pathology. 45(8). 1555–1562. 49 indexed citations
3.
Terzolo, Massimo, Barbara Allasino, A. Pia, et al.. (2014). Surgical remission of Cushing's syndrome reduces cardiovascular risk. European Journal of Endocrinology. 171(1). 127–136. 18 indexed citations
4.
Volante, Marco, Massimo Terzolo, Martin Faßnacht, et al.. (2012). Ribonucleotide Reductase Large Subunit ( RRM1 ) Gene Expression May Predict Efficacy of Adjuvant Mitotane in Adrenocortical Cancer. Clinical Cancer Research. 18(12). 3452–3461. 52 indexed citations
5.
Terzolo, Massimo, Arianna Ardito, Barbara Zaggia, et al.. (2012). Management of adjuvant mitotane therapy following resection of adrenal cancer. Endocrine. 42(3). 521–525. 29 indexed citations
6.
Hermsen, I G C, Martin Faßnacht, Massimo Terzolo, et al.. (2011). Plasma Concentrations of o,p′DDD, o,p′DDA, and o,p′DDE as Predictors of Tumor Response to Mitotane in Adrenocortical Carcinoma: Results of a Retrospective ENS@T Multicenter Study. The Journal of Clinical Endocrinology & Metabolism. 96(6). 1844–1851. 127 indexed citations
7.
Berruti, Alfredo, Paola Sperone, Annamaria Ferrero, et al.. (2011). Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma. European Journal of Endocrinology. 166(3). 451–458. 104 indexed citations
8.
Berruti, Alfredo, Paola Sperone, Elisa Bellini, et al.. (2011). Metronomic Therapy Concepts in the Management of Adrenocortical Carcinoma. Hormones and Cancer. 2(6). 378–384. 11 indexed citations
9.
Gentilin, Erica, Fulvia Daffara, Giuseppe Reimondo, et al.. (2010). Therapeutic concentrations of mitotane inhibit thyrotroph cell viability and TSH secretion in a mouse cell line model. Institutional Research Information System University of Ferrara (University of Ferrara). 22. 3 indexed citations
10.
Porpiglia, F., Cristian Fiori, Fulvia Daffara, et al.. (2010). Retrospective Evaluation of the Outcome of Open Versus Laparoscopic Adrenalectomy for Stage I and II Adrenocortical Cancer. European Urology. 57(5). 873–878. 134 indexed citations
11.
Porpiglia, F., Cristian Fiori, Roberto Mario Scarpa, et al.. (2009). 740 THE ROLE OF SURGERY IN THE MANAGEMENT OF RECURRENT ADRENOCORTICAL CARCINOMA: RESULTS OF A RETROSPECTIVE STUDY. European Urology Supplements. 8(4). 305–305. 5 indexed citations
12.
Daffara, Fulvia, Silvia De Francia, Giuseppe Reimondo, et al.. (2008). Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly. Endocrine Related Cancer. 15(4). 1043–1053. 119 indexed citations
13.
Berruti, Alfredo, Annamaria Ferrero, Paola Sperone, et al.. (2008). Emerging drugs for adrenocortical carcinoma. Expert Opinion on Emerging Drugs. 13(3). 497–509. 24 indexed citations
14.
Reimondo, Giuseppe, Anna Pia, Silvia Bovio, et al.. (2007). Laboratory differentiation of Cushing's syndrome. Clinica Chimica Acta. 388(1-2). 5–14. 31 indexed citations
15.
Pirro, Elisa, Francesca Martino, Andrea Elio Sprio, et al.. (2006). A new simple HPLC method for measuring mitotane and its two principal metabolites. Journal of Chromatography B. 837(1-2). 69–75. 27 indexed citations
16.
Volante, Marco, Paola Sperone, Enrico Bollito, et al.. (2006). Matrix metalloproteinase type 2 expression in malignant adrenocortical tumors: diagnostic and prognostic significance in a series of 50 adrenocortical carcinomas. Modern Pathology. 19(12). 1563–1569. 33 indexed citations
17.
Terzolo, Massimo, Giuseppe Reimondo, Maurizio Gasperi, et al.. (2005). Colonoscopic Screening and Follow-Up in Patients with Acromegaly: A Multicenter Study in Italy. The Journal of Clinical Endocrinology & Metabolism. 90(1). 84–90. 90 indexed citations
18.
Minetto, Marco Alessandro, Andrea Dovio, Mara Ventura, et al.. (2003). Interleukin-6 producing pheochromocytoma presenting with acute inflammatory syndrome. Journal of Endocrinological Investigation. 26(5). 453–457. 36 indexed citations
19.
Terzolo, Massimo, Anna Pia, Anna Alı̀, et al.. (2002). Adrenal Incidentaloma: A New Cause of the Metabolic Syndrome?. The Journal of Clinical Endocrinology & Metabolism. 87(3). 998–1003. 264 indexed citations
20.
Terzolo, Massimo, Giuseppe Reimondo, Anna Alı̀, et al.. (2001). Ectopic ACTH syndrome: Molecular bases and clinical heterogeneity. Annals of Oncology. 12. S83–S87. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026